Document Detail


Continuous versus intermittent angiotensin converting enzyme inhibition in renal hypertensive rats.
MedLine Citation:
PMID:  8340154     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Converting enzyme inhibitors impair renal function of the kidney beyond a stenosis of the renal artery in humans and induce histological lesions in the clipped kidney of renal hypertensive rats. In two-kidney, one clip hypertensive rats, we compared the time course and magnitude of the biochemical effects of angiotensin converting enzyme inhibition on the plasma renin-angiotensin system, cardiac hypertrophy, renal lesions, and 24-hour blood pressure decrease induced by either intermittent angiotensin converting enzyme inhibition administration (benazepril PO, 10 mg/kg once a day, n = 93) or continuous administration (benazeprilat, 3 mg/kg per day via osmotic pumps, n = 92). Control rats (n = 91) received the drug vehicle intermittently or continuously. Mortality was significantly reduced by both intermittent (n = 3/93) and continuous (n = 3/92) inhibition compared with controls (n = 18/91) (P < .001). Changes in the plasma renin-angiotensin system and blood pressure were parallel. A continuous suppression of the activity of the plasma renin-angiotensin system was associated with a 24-hour decrease in blood pressure with continuous inhibition, whereas intermittent inhibition induced a similar fall in blood pressure only for the first hours after gavage.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
T Battle; C Schnell; B Bunkenburg; D Heudes; J M Wood; J Ménard
Related Documents :
1006184 - Effect of kidney resection on blood pressure and plasma renin activity. case report and...
943254 - Plasma renin activity (pra) and aldosterone (pa) in patients with chronic glomeruloneph...
12431444 - Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on...
6990284 - Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-urae...
9167114 - Determinants of progression of microalbuminuria in patients with niddm.a prospective st...
23453324 - Design, application and impact of quality improvement 'theme months' in orthopaedic nur...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hypertension     Volume:  22     ISSN:  0194-911X     ISO Abbreviation:  Hypertension     Publication Date:  1993 Aug 
Date Detail:
Created Date:  1993-09-02     Completed Date:  1993-09-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  188-96     Citation Subset:  IM    
Affiliation:
Cardiovascular Research, CIBA-GEIGY Ltd., Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / blood
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Animals
Benzazepines / blood,  pharmacology*
Blood Pressure / drug effects
Creatinine / blood
Fibrosis
Heart Rate / drug effects
Hypertension, Renovascular / blood,  pathology,  physiopathology*
Kidney / drug effects,  pathology,  physiopathology
Male
Myocardium / pathology
Organ Size
Rats
Rats, Wistar
Renin / blood
Urea / blood
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Benzazepines; 11128-99-7/Angiotensin II; 57-13-6/Urea; 60-27-5/Creatinine; 86541-75-5/benazepril; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term ouabain administration produces hypertension in rats.
Next Document:  Thromboxane A2 receptor antagonism and synthase inhibition in essential hypertension.